Page, Elyse C. http://orcid.org/0000-0002-8990-2574
Heatley, Susan L. http://orcid.org/0000-0001-7497-6477
Eadie, Laura N.
McClure, Barbara J. http://orcid.org/0000-0002-5201-4127
de Bock, Charles E.
Omari, Sofia http://orcid.org/0000-0003-0345-5601
Yeung, David T.
Hughes, Timothy P.
Thomas, Paul Q.
White, Deborah L. http://orcid.org/0000-0003-4844-333X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1057746, APP1044884)
Leukaemia Foundation
Article History
Received: 21 June 2021
Revised: 10 November 2021
Accepted: 17 November 2021
First Online: 2 December 2021
Competing interests
: D.L.W. receives research support from BMS, and Honoraria from BMS and AMGEN. D.T.Y. receives research support from BMS & Novartis, and Honoraria from BMS, Novartis, Pfizer, and AMGEN. T.P.H. receives research support from BMS & Novartis, and Honoraria from BMS, Novartis, and Fusion Pharma. None of these agencies have had a role in the preparation of this manuscript. All other authors declare no conflicts of interest.
: Experiments with mice were conducted according to the guidelines of the South Australian Health and Medical Research Institute animal ethics committee. Ethical approval was obtained from each institutional Human Research Ethics Committee and parents or legal guardians gave informed, written consent. This study was conducted in accordance with the Declaration of Helsinki.
: This original work is not published elsewhere, and is not under consideration elsewhere for publication.